Published online Dec 25, 2024. doi: 10.5501/wjv.v13.i4.98600
Revised: August 26, 2024
Accepted: August 28, 2024
Published online: December 25, 2024
Processing time: 109 Days and 17.6 Hours
Core Tip: Respiratory viral co-infections significantly complicate clinical management due to their impact on disease severity and patient outcomes. Current diagnostic techniques often miss these co-infections, making it difficult to accurately define their epidemiology and management strategies. Research suggests that co-infections can exacerbate illnesses, leading to higher hospitalization rates and increased healthcare utilization, particularly among high-risk groups such as children, the elderly, and immunocompromised individuals. Thus, advancing diagnostic methods and developing targeted therapeutic strategies are essential for improving public health interventions and patient outcomes. Understanding the virological interactions and immune response during co-infections is crucial for these advancements.
